WuXi AppTec Closes at IPO Price on First Day of Hong Kong Trading

TRENDING: ByteDance Targets July Launch of Upgraded AI Video Model; Embodied AI Startup Kunlunxing Lands Multibillion Yuan Raise; Europe Has a Lot to Learn From China About Electric Trucks, Volvo CTO Says

LATEST: Europe Has a Lot to Learn From China About Electric Trucks, Volvo CTO Says; Embodied AI Startup Kunlunxing Lands Multibillion Yuan Raise; ByteDance Targets July Launch of Upgraded AI Video Model; China’s Starlink Challenger Seeks Up to $2.2 Billion for Satellite Network Push; New Model Propels Zhipu AI’s Market Value to Record HK$1 Trillion; In AI Pitch, Alibaba Chairman Urges Europe to Look Beyond U.S. Tech; Cover Story: China’s AI Boom Is Rewiring Its Power Grid; In Depth: How AI Is Rewiring White-Collar Work in China; Chipmaker YMTC Cedes Control of Foundry Unit Ahead of Mega IPO; Chinese Startup Manifold AI Raises Fresh Funding as Investors Bet on ‘World Models’; Crealights Takes Step Closer to Hong Kong IPO as Data Center Boom Fuels Growth Prospects; Tencent Lets AI Agent Make Purchases Through WeChat Pay; Galaxea AI Chief Says China Could Lead Robotics Models Within Three Years; SiliconFlow Raises $294 Million as China’s AI Inference Demand Surges; Ant Revamps Alipay With AI Assistant in Biggest App Overhaul; New Model Sends Zhipu AI’s Stock Soaring; DJI, Insta360 File Competing U.S. Patent Lawsuits Over Camera Tech; Cover Story: When Employees Leave, Their AI Clones Carry on Working; AI Stocks Zhipu, MiniMax Slide as Lock-Up Expirations Near; Japan’s Chip Exports to China Surge as Bilateral Trade Rebounds

By Charlotte Yang / Dec 13, 2018 05:17 PM / Business & Tech

WuXi AppTech executives at the Shanghai exchange in May. Photo: VCG

Hong Kong shares of biotech superstar WuXi AppTec began their first day of trading Thursday at HK$67, and closed at their IPO price of HK$68.

WuXi AppTec is among an emerging group of fast-growing Chinese biotech firms that are tapping financial markets at home and abroad. But unlike many of its peers, WuXi AppTec is profitable, as others lose money while their drugs go through clinical trials and await regulatory approval.

In May, the firm surged 44% on its Shanghai debut, rising from an IPO price of 21.6 yuan ($3.14) to 31.1 yuan and hitting Shanghai’s daily increase limit for newly-listed shares.

Share this article

Open WeChat and scan the QR code